Endovascular treatment of aorto-iliac occlusive disease with TASC II C and D lesions: 10 year’s experience of clinical technique
Abstract Objectives The purpose of this study was to evaluate the therapeutic efficacy and safety of endovascular treatment aorto-iliac occlusive disease (AIOD) with TransAtlantic Inter-Society Consensus II (TASC II) C and D lesions. In addition, 10 years of experience with interventional procedures...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2023-02-01
|
| Series: | BMC Cardiovascular Disorders |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12872-023-03059-4 |
| _version_ | 1811166048870727680 |
|---|---|
| author | Xiangjun Dong Ziqian Peng Yanqiao Ren Lei Chen Tao Sun Yangbo Su Huimin Liang Chuansheng Zheng |
| author_facet | Xiangjun Dong Ziqian Peng Yanqiao Ren Lei Chen Tao Sun Yangbo Su Huimin Liang Chuansheng Zheng |
| author_sort | Xiangjun Dong |
| collection | DOAJ |
| description | Abstract Objectives The purpose of this study was to evaluate the therapeutic efficacy and safety of endovascular treatment aorto-iliac occlusive disease (AIOD) with TransAtlantic Inter-Society Consensus II (TASC II) C and D lesions. In addition, 10 years of experience with interventional procedures and treatment options in our center were also worthy of further discussion. Methods Between January 2011 and December 2020, a total of 26 consecutive AIOD patients with TASC-II C and D lesions treated endovascular approach were enrolled in this study. Patients' demographic and clinical data were collected, and the safety and efficacy of endovascular therapy were evaluated. In addition, operation procedures were also described. Results The mean age of patients was 62.2 ± 7 years (49–57 years), and the mean body mass index of patients was 24.2 ± 2.6 kg/m2. Fifteen patients (57.7%) were Rutherford 4, 5 each (19.2%) were Rutherford 3 and 5, and 1 (3.8%) was Rutherford 2. No other serious complications occurred except death in 3 patients. Most of the patients (73.1%) had a history of smoking, and hypertension and hyperlipidemia were common comorbidities. Endovascular therapy was successfully performed in 25 patients, and the technical success rate was 96.2%. The patient's ankle-brachial index improved significantly postoperatively compared with preoperatively (preoperative 0.33 ± 0.14 vs 1.0 ± 0.09, P < 0.001). The primary patency rates were 100%, 95.7%, and 91.3% at 1, 3, and 5 years, while the secondary patency rates were 100%. No treatment-related deaths or serious complications occurred. Conclusions Endovascular treatment of AIOD patients with TASC-II C and D lesions might be safe and have a high rate of middle-term and long-term primary patency. |
| first_indexed | 2024-04-10T15:46:08Z |
| format | Article |
| id | doaj.art-30ffa80d31f44c74bb9ae88645f732a8 |
| institution | Directory Open Access Journal |
| issn | 1471-2261 |
| language | English |
| last_indexed | 2024-04-10T15:46:08Z |
| publishDate | 2023-02-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Cardiovascular Disorders |
| spelling | doaj.art-30ffa80d31f44c74bb9ae88645f732a82023-02-12T12:04:04ZengBMCBMC Cardiovascular Disorders1471-22612023-02-012311710.1186/s12872-023-03059-4Endovascular treatment of aorto-iliac occlusive disease with TASC II C and D lesions: 10 year’s experience of clinical techniqueXiangjun Dong0Ziqian Peng1Yanqiao Ren2Lei Chen3Tao Sun4Yangbo Su5Huimin Liang6Chuansheng Zheng7Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Radiology, Yingshan People’s HospitalDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyAbstract Objectives The purpose of this study was to evaluate the therapeutic efficacy and safety of endovascular treatment aorto-iliac occlusive disease (AIOD) with TransAtlantic Inter-Society Consensus II (TASC II) C and D lesions. In addition, 10 years of experience with interventional procedures and treatment options in our center were also worthy of further discussion. Methods Between January 2011 and December 2020, a total of 26 consecutive AIOD patients with TASC-II C and D lesions treated endovascular approach were enrolled in this study. Patients' demographic and clinical data were collected, and the safety and efficacy of endovascular therapy were evaluated. In addition, operation procedures were also described. Results The mean age of patients was 62.2 ± 7 years (49–57 years), and the mean body mass index of patients was 24.2 ± 2.6 kg/m2. Fifteen patients (57.7%) were Rutherford 4, 5 each (19.2%) were Rutherford 3 and 5, and 1 (3.8%) was Rutherford 2. No other serious complications occurred except death in 3 patients. Most of the patients (73.1%) had a history of smoking, and hypertension and hyperlipidemia were common comorbidities. Endovascular therapy was successfully performed in 25 patients, and the technical success rate was 96.2%. The patient's ankle-brachial index improved significantly postoperatively compared with preoperatively (preoperative 0.33 ± 0.14 vs 1.0 ± 0.09, P < 0.001). The primary patency rates were 100%, 95.7%, and 91.3% at 1, 3, and 5 years, while the secondary patency rates were 100%. No treatment-related deaths or serious complications occurred. Conclusions Endovascular treatment of AIOD patients with TASC-II C and D lesions might be safe and have a high rate of middle-term and long-term primary patency.https://doi.org/10.1186/s12872-023-03059-4Aorto-iliac occlusive diseaseTASC C and D lesionsEndovascular proceduresPrimary patencyIntervention experience |
| spellingShingle | Xiangjun Dong Ziqian Peng Yanqiao Ren Lei Chen Tao Sun Yangbo Su Huimin Liang Chuansheng Zheng Endovascular treatment of aorto-iliac occlusive disease with TASC II C and D lesions: 10 year’s experience of clinical technique BMC Cardiovascular Disorders Aorto-iliac occlusive disease TASC C and D lesions Endovascular procedures Primary patency Intervention experience |
| title | Endovascular treatment of aorto-iliac occlusive disease with TASC II C and D lesions: 10 year’s experience of clinical technique |
| title_full | Endovascular treatment of aorto-iliac occlusive disease with TASC II C and D lesions: 10 year’s experience of clinical technique |
| title_fullStr | Endovascular treatment of aorto-iliac occlusive disease with TASC II C and D lesions: 10 year’s experience of clinical technique |
| title_full_unstemmed | Endovascular treatment of aorto-iliac occlusive disease with TASC II C and D lesions: 10 year’s experience of clinical technique |
| title_short | Endovascular treatment of aorto-iliac occlusive disease with TASC II C and D lesions: 10 year’s experience of clinical technique |
| title_sort | endovascular treatment of aorto iliac occlusive disease with tasc ii c and d lesions 10 year s experience of clinical technique |
| topic | Aorto-iliac occlusive disease TASC C and D lesions Endovascular procedures Primary patency Intervention experience |
| url | https://doi.org/10.1186/s12872-023-03059-4 |
| work_keys_str_mv | AT xiangjundong endovasculartreatmentofaortoiliacocclusivediseasewithtasciicanddlesions10yearsexperienceofclinicaltechnique AT ziqianpeng endovasculartreatmentofaortoiliacocclusivediseasewithtasciicanddlesions10yearsexperienceofclinicaltechnique AT yanqiaoren endovasculartreatmentofaortoiliacocclusivediseasewithtasciicanddlesions10yearsexperienceofclinicaltechnique AT leichen endovasculartreatmentofaortoiliacocclusivediseasewithtasciicanddlesions10yearsexperienceofclinicaltechnique AT taosun endovasculartreatmentofaortoiliacocclusivediseasewithtasciicanddlesions10yearsexperienceofclinicaltechnique AT yangbosu endovasculartreatmentofaortoiliacocclusivediseasewithtasciicanddlesions10yearsexperienceofclinicaltechnique AT huiminliang endovasculartreatmentofaortoiliacocclusivediseasewithtasciicanddlesions10yearsexperienceofclinicaltechnique AT chuanshengzheng endovasculartreatmentofaortoiliacocclusivediseasewithtasciicanddlesions10yearsexperienceofclinicaltechnique |